U.S., Dec. 31 -- An application to own the trademark for 'CAJAL THERAPEUTICS' has been filed on Jun. 06, 2025.
Owner(s):
Cajal Therapeutics Inc.; 1150 Eastlake Avenue East, Suite 700, , WASHINGTON
Goods and/or Services:
For: Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, hepatological, ophthalmic, cardiometabolic, pulmonary, nephrological, respiratory, neurological, neuromuscular, gastrointestinal, hormonal, dermatological, psychiatric, and sexually transmitted diseases, conditions, and disorders.
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Pharmaceutical research and development; drug discovery service...